Exclusive: Rock Band Unplugged Track List

AOL Money & Finance

Closing Bell: Frankly S&P......

More

If you wanted two situations to describe today's rally, first you can thank S&P and second you can thank Barney Frank. S&P and Moody's have had the markets by the you-know-whats, but today they issued a report calling "the end in sight" on write downs.

Congressman Barney Frank was out calling for the FHA to get involved as a mortgage backstop to help one or two million mortgage holders. It is pretty impressive that the market rallied when we simultaneously saw gold hit $1,000/ounce and oil hit $110/barrel. Below are the unofficial closing levels for the markets.
  • DJIA 12,145.74 (+35.50; +0.29%)
  • S&P500 1,315.48 (+6.71; +0.51%)
  • NASDAQ 2,263.61 (+19.74; +0.88%)
  • 10 Yr T-Bond 3.534% (+0.051%)
  • 52-week stand-out stocks
Retail sales for February came in negative territory, but you would have to be named Dr. Pangloss to expect any great numbers on the retail front right now. Weekly jobless claims also came in at 353,000, not much different than the week before; and import prices came in at levels that weren't screaming inflation ahead.

The real surprise cam from Humana (NYSE: HUM) with a gain of 10% to $44.98 after it received another brokerage upgrade. That is actually up a whopping 30% or more from yesterday's lows, proof that not all gap-downs are created equal.

Shares of Yahoo! (NASDAQ: YHOO) saw a sharp drop at the end of the day as a rumored major-seller was looking to get out. Shares closed down 3.3% at $27.50. Merger-arb players have some concerns here.

Cumulus Media Inc. (NASDAQ: CMLS) was another stand-out winner with a monster gain of 27.5% to $6.26 today. You can read about that full story at BloggingBuyouts. That merger spread had more than 100% to it at one point...... it might not be entirely dead after all.

LDK Solar Co., Ltd. (NYSE: LDK) was another huge winner with a 23% gain to $25.28. Guess whose solar wafer capacity is full booked for 2008 and almost all for 2009.

Amgen, Inc. (NASDAQ: AMGN) can thank its lucky stars after an almost 5% gain to $47.18. It's not totally off the hook on Anemia drugs, but the FDA panel meeting didn't totally kill its sales. More warnings and restrictions will be advised, but that isn't a death sentence. That stock has been cut in half since the end of 2005.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-223.328,280.74
NASDAQ-49.201,796.52
S&P 500-26.91896.42

Last updated: July 06, 2009: 08:14 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines